Mölndal, Sweden, October 1, 2025 – Profundus is a Swedish startup at the forefront of retinal diagnostics, developing the most advanced retinal camera and software system to enable early detection of retinal changes, facilitating early diagnosis, prevention and treatment of various diseases. Profundus is pleased to announce the appointment of Neven Zoric as its new Chief Executive Officer, effective October 1st.
Neven brings over 20 years of leadership experience across the life sciences, diagnostics, and medical device sectors. Most recently, he established and led the global commercial excellence function at Vitrolife Group, following his tenure as Vice President of Sales and Marketing for EMEA, where he managed a combination of direct and distributor channels and was responsible for a significant share of the company’s revenue. Prior to Vitrolife, Neven held several senior commercial positions at Thermo Fisher Scientific within its clinical diagnostics and research divisions.
“Profundus is an innovative company, on the verge of launching the most advanced retinal imaging device on the market. I am excited to join the team and lead the company through this pivotal phase, bringing our product to market and building a scalable, high-performing organization,” says Neven Zoric, CEO of Profundus.
”I’m pleased to welcome Neven to Profundus. We’re now taking the next step in the company’s development by obtaining CE marking for our innovative device and making it more widely available, with the potential to transform the retinal imaging field. To support this growth, we have strengthened our Board of Directors and leadership team. Neven’s industry expertise and commercial leadership will be important as we continue our mission to improve patient outcomes through earlier detection, monitoring, and treatment of eye disorders”, says Matti Ahlqvist, Chairman of the Board.
